Beijing Hotgen Biotech Co., Ltd. (SHA:688068)
China · Delayed Price · Currency is CNY 149.00
-3.44 (-2.26%)
At close: Jan 22, 2026
Beijing Hotgen Biotech Market Cap
Beijing Hotgen Biotech has a market cap or net worth of 13.24 billion as of January 22, 2026. Its market cap has increased by 144.43% in one year.
Market Cap
13.24B
Enterprise Value
12.19B
Revenue
434.45M
Ranking
n/a
PE Ratio
n/a
Stock Price
149.00
Market Cap Chart
Since September 30, 2019, Beijing Hotgen Biotech's market cap has increased from 4.41B to 13.24B, an increase of 200.20%. That is a compound annual growth rate of 19.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 13.54B | -5.90% |
| Dec 31, 2025 | 14.39B | 159.78% |
| Dec 31, 2024 | 5.54B | 50.94% |
| Dec 29, 2023 | 3.67B | -34.53% |
| Dec 30, 2022 | 5.61B | -22.40% |
| Dec 31, 2021 | 7.22B | 197.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mabwell (Shanghai) Bioscience | 15.74B |
| Tibet Cheezheng Tibetan Medicine | 13.84B |
| Pacific Shuanglin Bio-pharmacy | 13.36B |
| Staidson (Beijing) BioPharmaceuticals | 13.23B |
| HitGen | 13.11B |
| Aurisco Pharmaceutical | 12.65B |
| Youcare Pharmaceutical Group | 12.37B |
| Vcanbio Cell & Gene Engineering Corp., | 12.26B |